Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $33,358 - $37,341
539 Added 75.92%
1,249 $84,000
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $9,403 - $10,396
-145 Reduced 16.96%
710 $48,000
Q2 2023

Aug 14, 2023

SELL
$69.91 - $75.81 $32,647 - $35,403
-467 Reduced 35.33%
855 $61,000
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $44,331 - $50,263
-702 Reduced 34.68%
1,322 $91,000
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $109,721 - $142,570
2,024 New
2,024 $137,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Resurgent Financial Advisors LLC Portfolio

Follow Resurgent Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.